EXPANSION OF THE PEDIATRIC AIDS CLINICAL TRIAL GROUP

扩大儿科艾滋病临床试验组

基本信息

  • 批准号:
    3547247
  • 负责人:
  • 金额:
    $ 124.14万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1989
  • 资助国家:
    美国
  • 起止时间:
    1989-09-30 至 1993-08-31
  • 项目状态:
    已结题

项目摘要

This is an already existing and functional interdisciplinary multicentered consortium of experts dedicated to health care, clinical as well as basic research related to HIV infection in children (PAIDS) and pregnant women. Members of this Bronx based network include health care professionals, biostatisticians, pharmacologists, and scientists in the filed of pediatrics, immunology, infectious diseases, microbiology, molecular biology and genetics. The network effectively covers the Bronx the largest epicenter of pediatrics AIDS nationwide. It is the first and largest PAIDS center in the USA> The projected new pediatric HIV infected newborns in the geographic catchment area of the consortium is also the largest, with over 4% of all cord bloods being HIV antibody positive. Members of the group have gained experience in adult ATEU trials and in pediatric treatments designed at AECOM. The development of a pediatric ACTG will complement our existing efforts by enabling us to include adult and pediatric members of the same HIV infected family in therapeutic trials. Such an AIDS Family oriented approach has improved enrollment and longterm compliance. The Albert Einstein College of Medicine PAIDS Cooperative Treatment Group will interact with the NIH ACTGs to foster research aimed at the design of novel therapeutic approaches in the areas of immune reconstitution, anti-HIV agents and treatment trials for HIV related diseases.
这是一个已经存在的和功能性的跨学科

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Arye Rubenstein其他文献

Arye Rubenstein的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Arye Rubenstein', 18)}}的其他基金

CORE--VACCINE AND IMMUNOLOGY
核心——疫苗与免疫学
  • 批准号:
    6099394
  • 财政年份:
    1998
  • 资助金额:
    $ 124.14万
  • 项目类别:
MULTI EPITOPE HIV PEPTIDE AND V1/V2 PROTEIN VACCINES
多表位 HIV 肽和 V1/V2 蛋白疫苗
  • 批准号:
    2627924
  • 财政年份:
    1998
  • 资助金额:
    $ 124.14万
  • 项目类别:
CORE--VACCINE AND IMMUNOLOGY
核心——疫苗与免疫学
  • 批准号:
    6267994
  • 财政年份:
    1998
  • 资助金额:
    $ 124.14万
  • 项目类别:
PREVENTIVE AND THERAPEUTIC PEPTIDE AIDS VACCINES
预防性和治疗性肽艾滋病疫苗
  • 批准号:
    6100223
  • 财政年份:
    1998
  • 资助金额:
    $ 124.14万
  • 项目类别:
CORE--VACCINE AND IMMUNOLOGY
核心——疫苗与免疫学
  • 批准号:
    6234902
  • 财政年份:
    1997
  • 资助金额:
    $ 124.14万
  • 项目类别:
TRANSPLACENTAL PASSAGE OF HIV AND IMMUNOGLOBULIN
HIV 和免疫球蛋白的经胎盘传递
  • 批准号:
    2067177
  • 财政年份:
    1991
  • 资助金额:
    $ 124.14万
  • 项目类别:
EXPANSION OF THE PEDIATRIC AIDS CLINICAL TRIAL GROUP
扩大儿科艾滋病临床试验组
  • 批准号:
    3547254
  • 财政年份:
    1989
  • 资助金额:
    $ 124.14万
  • 项目类别:
EXPANSION OF THE PEDIATRIC AIDS CLINICAL TRIAL GROUP
扩大儿科艾滋病临床试验组
  • 批准号:
    3547253
  • 财政年份:
    1989
  • 资助金额:
    $ 124.14万
  • 项目类别:
EXPANSION OF THE PEDIATRIC AIDS CLINICAL TRIAL GROUP
扩大儿科艾滋病临床试验组
  • 批准号:
    3547251
  • 财政年份:
    1989
  • 资助金额:
    $ 124.14万
  • 项目类别:
EXPANSION OF THE PEDIATRIC AIDS CLINICAL TRIAL GROUP
扩大儿科艾滋病临床试验组
  • 批准号:
    3547249
  • 财政年份:
    1989
  • 资助金额:
    $ 124.14万
  • 项目类别:

相似海外基金

Basic and applied study on AIDS-therapy using hybrid liposomes
混合脂质体治疗艾滋病的基础与应用研究
  • 批准号:
    24656509
  • 财政年份:
    2012
  • 资助金额:
    $ 124.14万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
SIV MODEL FOR MULTI DRUG RESISTANCE TO AIDS THERAPY
艾滋病治疗多重耐药性的 SIV 模型
  • 批准号:
    6940442
  • 财政年份:
    2003
  • 资助金额:
    $ 124.14万
  • 项目类别:
RT-SHIV MODEL FOR RESISTANCE TO AIDS THERAPY
艾滋病治疗抵抗力的 RT-SHIV 模型
  • 批准号:
    6940441
  • 财政年份:
    2003
  • 资助金额:
    $ 124.14万
  • 项目类别:
Mitochondrial Toxicity of Antiviral Nucleosides in AIDS Therapy
艾滋病治疗中抗病毒核苷的线粒体毒性
  • 批准号:
    7421121
  • 财政年份:
    2002
  • 资助金额:
    $ 124.14万
  • 项目类别:
TARGETED MANIPULATION OF STEM CELLS FOR AIDS THERAPY
干细胞的靶向操作用于艾滋病治疗
  • 批准号:
    6312501
  • 财政年份:
    2001
  • 资助金额:
    $ 124.14万
  • 项目类别:
TARGETED MANIPULATION OF STEM CELLS FOR AIDS THERAPY
干细胞的靶向操作用于艾滋病治疗
  • 批准号:
    6499098
  • 财政年份:
    2001
  • 资助金额:
    $ 124.14万
  • 项目类别:
Targeted Manipulation of Stem Cells for AIDS Therapy
干细胞的靶向操作用于艾滋病治疗
  • 批准号:
    7479315
  • 财政年份:
    2001
  • 资助金额:
    $ 124.14万
  • 项目类别:
TARGETED MANIPULATION OF STEM CELLS FOR AIDS THERAPY
干细胞的靶向操作用于艾滋病治疗
  • 批准号:
    6708893
  • 财政年份:
    2001
  • 资助金额:
    $ 124.14万
  • 项目类别:
Targeted Manipulation of Stem Cells for AIDS Therapy
干细胞的靶向操作用于艾滋病治疗
  • 批准号:
    7666728
  • 财政年份:
    2001
  • 资助金额:
    $ 124.14万
  • 项目类别:
TARGETED MANIPULATION OF STEM CELLS FOR AIDS THERAPY
干细胞的靶向操作用于艾滋病治疗
  • 批准号:
    6849724
  • 财政年份:
    2001
  • 资助金额:
    $ 124.14万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了